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CASE STUDY
Life‑threatening cardiac episode in a 
Polish patient carrying contiguous gene 
microdeletion of the TBX5 and the TBX3 genes
Katarzyna Iwanicka‑Pronicka1,2*, Magdalena Socha3, Maria Jędrzejowska1, Małgorzata Krajewska‑Walasek1 
and Aleksander Jamsheer3,4
Abstract 
Holt–Oram syndrome (HOS) features radial ray hypoplasia, heart defect and cardiac conduction impairment. Ulnar‑
mammary syndrome (UMS) characterizes congenital defects of the ulnar side of the upper limbs, underdevelop‑
ment of apocrine glands including hypoplasia and the dysfunction of mammary glands, hypogonadism and obesity. 
Inheritance of both conditions is autosomal dominant, mutations or deletions are found in the TBX5 and TBX3 gene, 
respectively. The Polish patient presented short stature, obesity, congenital malformation of the radial and ulnar side 
of the upper limbs, heart block, hypogonadism and dysmorphic features. At the age of 13 years he lost conscious‑
ness developing respiratory insufficiency caused by bradycardia in the course of sudden atrioventricular third degree 
heart block requiring immediate implantation of pace maker‑defibrillator device. Microdeletion of the 12q24.21 was 
identified using array CGH method. This region includes contiguous genes the TBX5, TBX3, and part of RBM19. The 
patient initially diagnosed as having HOS, was found to present the UMS features as well. Array CGH method should 
be applied in patients suspected of HOS or UMS, especially when sequencing of TBX5 or TBX3 genes fails to identify 
causative mutation.
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Background
Holt–Oram syndrome (HOS, OMIM 142900) is a 
genetic condition characterized by radial ray hypo-
plasia and congenital heart defect often associated 
with progressive arrhythmias and dysmorphic fea-
tures (Holt and Oram 1960; Harris and Osborne 1966). 
The syndrome is usually caused by point mutations or 
intragenic deletions of the TBX5 gene, however in rare 
cases it results from larger deletions encompassing 
the entire TBX5 coding sequence (Basson et  al. 1997; 
Gruenauer-Kloevekorn and Froster 2003; Newbury-
Ecob et  al. 1996). Ulnar-mammary syndrome (UMS, 
OMIM 181450) is a congenital malformation syndrome 
characterized by the ulnar hypoplasia of the upper 
limbs, usually comprising absent or hypoplastic 5th 
and/or 4th fingers, absent or hypoplastic ulna, under-
development of the apocrine glands resulting in the 
dysfunction of the mammary and axillary glands, hypo-
gonadism with genital anomalies and delayed puberty 
in males, obesity, absence of axillary hair and tooth 
abnormalities (Schinzel 1987; Pallister et  al. 1976). 
UMS also referred to as Schinzel syndrome or Pallis-
ter ulnar-mammary syndrome can result from either 
point mutations or deletions of the TBX3 gene (Bam-
shad et al. 1997; Linden et al. 2009). Microdeletions of 
the 12q24.21 region comprising the two neighbouring 
TBX5 and TBX3 genes lead to the phenotype charac-
terized by a combination of the clinical symptoms asso-
ciated with both disorders (Borozdin et  al. 2006; Alby 
et al. 2013; Bogarapu et al. 2014).
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Case description
This boy was born at term, by Caesarean section due to 
foetal bradycardia. His birth weight was of 2700 g, length 
of 51  cm, and Apgar score of 2-2-2-7 points at 1, 3, 5, 
15 min, respectively. The early psychomotor and intellec-
tual development was normal and the boy attended pub-
lic school. His parents, younger sister and two maternal 
half-siblings are healthy.
He was referred to our Institute at the age of 14 years 
due to dysmorphic features, congenital malformations 
of the upper limbs, heart block, and hypogonadism. The 
boy presented with short stature 145 cm (<3 pc), promi-
nent truncal obesity 48 kg (25–50 pc), steatomastia, and 
hypoplastic, low set nipples. His neck was short with 
lower hairline and downsloping shoulders Fig. 1. The face 
was oval in shape with fat accumulation under the chin. 
Dysmorphic features included hypertelorism, epicanthal 
folds, slanting downwards palpebral fissures, long nose, 
long philtrum and small mouth with narrow upper lip set 
of the horseshoe shape. The ears were slightly protrud-
ing with thick lobes and recurvate helix. Anomalies in 
the oral cavity included high-arched palate and overlap-
ping, crowded teeth. Additionally, he had small hypo-
plastic penis embedded in adipose tissue, right-sided 
cryptorchidism, underdeveloped, shawl scrotum contain-
ing a small left testicle.
Skeletal malformations comprised hypoplasia of pec-
toral muscles, shortening of forearms, bilateral hypo-
plasia of radial side of the hands (with small, hypoplastic 
biphalangeal yet non-opposable thumbs), hypoplasia 
of thenar and hypothenar eminences and brachydactyly 
Fig.  1. Radiologic examination revealed 3-years delay in 
carpal ossification Fig.  1. Echocardiography revealed 
mitral valve regurgitation without any structural abnor-
malities. At age of 13 years the boy suddenly developed 
cardiac arrhythmia leading to unconsciousness and rap-
idly progressive lung oedema. He required mechanical 
ventilation. This episode was followed by the develop-
ment of third degree heart block resulting in severe 
bradycardia about 47 beat per min and prolonged Q-T 
interval requiring implantation of endocavitary cardio-
verter defibrillator device.
Based on the phenotypic presentation and negative 
sequencing of the TBX5 gene, high-resolution array CGH 
method was applied. Heterozygous interstitial contigu-
ous gene deletion of the TBX5 and TBX3 encompass-
ing 1.79  Mb of the chromosome 12q24.21 region was 
revealed and subsequently confirmed by qPCR. The 
Fig. 1 The patient’s silhouette. Rtg of the patient’s hands. Anterior and posterior palmar surface of the left hand of the patient
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minimal genomic coordinates of the detected deletion 
were 114297717–116091603 according to hg19 database 
Fig. 2. Paternal origin of the deletion was excluded with 
the use of qPCR, while maternal DNA was unavailable 
for testing.
Discussion and evaluation
We describe a Polish proband presenting the overlapping 
phenotype of HOS and UMS, resulting from contiguous 
microdeletion comprising the TBX5, TBX3 and a part 
of RBM19 genes, located on chromosome 12q24.21. To 
date, similar molecular defects and clinical phenotypes 
have been described only in seven patients from four 
unrelated families. The size of the microdeletions varied 
among the patients, although our case carrying smaller 
than previously described changes presented the most 
severe, life-threatening cardiological symptoms and 
dysmorphia.
The first description of HOS and UMS overlap was pro-
vided by Borozdin et  al. (2006), who presented a Czech 
family: the mother and her two daughters. A size of the 
microdeletion identified in those patients was delineated 
as 2.19 to 2.27 Mb, slightly larger than in our patient. Dis-
tinct dysmorphic features of those patients compared to 
our proband included hypertrichosis of the hands, back, 
and genital region, cleft between 4th and 5th fingers and 
congenital heart defect (VSD and ASD). The most serious 
medical problem described in one child from the Czech 
family involved subglottic laryngeal stenosis requiring 
long-term ventilation through laryngeal tube.
The next report of Alby et  al. (2013) presented two 
unrelated French females and a foetus, all with contigu-
ous deletions encompassing 2.6 and 2.44 Mb also involv-
ing the TBX5 and TBX3 genes. Both women manifested 
mild clinical features being a combination of both syn-
dromes. One of them has additionally growth hormone 
deficiency, while her foetus presented with VSD and 
hypoplastic aorta.
The latest paper of Bogarapu et  al. (2014) described a 
boy of Spanish origin, who presented with social impair-
ment, speech and motor delay. Physically, the boy ful-
filled combined diagnostic criteria of HOS and UMS. 
Array CGH study performed in this patient revealed the 
presence of two deletions: one 3.1  Mb in size encom-
passing TBX5, TBX3 and 17 other genes, and the sec-
ond occurring at 12p13.33 and involving four genes. 
Since little is known about the function of the remain-
ing haploinsufficient genes, one can hypothesize on their 
Fig. 2 Array CGH profile of chromosome 12. Red frame at the chromosome 12 (at the bottom of the picture) localised in the region 12q24.21 
indicates the microdeletion of 1.79 Mb found in the Polish proband, encompassing the contignous genes: TBX5, TBX3, and part of the RBM19; the 
minimal genomic coordinates 12: 114297717–116091603—(hg19). Green frame shows the microdeletion of 2.2–2.3 Mb found in Borozdin’s Czech 
family: telomere end: 114,750,000–114,800,000; centromere end: 112,560,000–112,460,000). Blue and violet frames point the microdeletions of 2.44 
and 2.6 Mb found in French patients of Alby 12: 113,084,817–115,681,244—(hg19) and 12: 113,197,408–113,736,198—(hg18). Orange frame displays 
the microdeletion of 2.6 Mb found in the Spanish boy presented by Bogarapu 12: 112,963,559–116,095,198—(hg19)
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possible contribution to the development of the clinical 
and behavioural phenotype of this patient.
The RBM19 gene was found to be partially deleted in 
our proband. Literature data suggests the role of RBM19 
in the proliferation, differentiation, and development of 
the intestinal epithelium (Lorenzen et al. 2005). Although 
the impact of the partial deletion of this gene on pheno-
type is unknown, one can assume the substantial effect 
on phenotype of RBM19 haploinsufficiency, as well as 
other noncoding and enhancing regions for distal genes 
affected by partial deletion, or microRNA fragments 
potentially existing in non-coding sequences of the 
region.
The co-occurrence of cardiac involvement is more 
characteristic for deletions of the TBX5 gene that code 
a transcriptional activation factor promoting heart 
development, especially cardiac primordial structures 
(Bruneau et  al. 2001). However, a dysfunction of heart 
conduction system may also result from the TBX3 dele-
tion (Hoogaars et  al. 2007). Borozdin et  al. (2006) sug-
gested that the deletion of the TBX3 gene may probably 
enhance the severity of the cardiac phenotype caused 
by haploinsufficiency of the TBX5 gene. We believed 
that bradyarrhythmia observed in our patient is caused 
by TBX5 deletion, and is not enhanced by TBX3 
rearrangement.
It was described that TBX5 and TBX3 evolutionary 
derive from the common ancestral gene, and each of 
them acquired a complementary role in the development 
of mammalian upper limb (Boehme and Shotar 1989). A 
diversity of symptoms encountered in patients with the 
deletion of the TBX5 and TBX3 genes reflects their versa-
tile developmental role, involving the formation of heart, 
radial and ulnar side of forelimb, lungs, pharynx, tho-
rax, body wall, and mature retina (Borozdin et al. 2006). 
It should be stressed that the clinical features of patients 
carrying the rearrangement result not only from the lack 
of the deleted genes, but also from other existed undeter-
mined distal enhancer elements, or microRNAs as well.
Conclusions
The patient carrying a contiguous microdeletion of TBX5 
and TBX3 genes displays features of Holt–Oram Syn-
drome (HOS) and ulnar-mammary syndrome (UMS). 
The most prominent symptoms observed in our case are 
progressive arrhythmia leading to heart failure accompa-
nied by heart defect, bilateral upper limb malformation 
of the radial and ulnar side, short stature, obesity, hypo-
gonadism causing delayed puberty, hypoplastic apocrine 
glands, teeth anomalies and dysmorphia. Such molecu-
lar defect may be detected using array CGH method. 
The size of the microdeletion encompassing the region 
of 12q24.21 does not strictly influence the severity of 
the phenotype. Polish patient presenting with the most 
severe clinical manifestation in reference to the previ-
ously described patients, carries the smallest molecular 
change. Numerous health complications seen in patients 
with haploinsufficiency of the TBX5 and TBX3 genes 
entail a multidisciplinary care. Critical heart complica-
tion in our case suggests need for thorough cardiological 
monitoring, because of risk for sudden heart insuffi-
ciency resulting from the progressive conduction impair-
ment. Affected newborns showing respiration problems 
should be suspected of having subglottic laryngeal steno-
sis, thus they require immediate phoniatric management.
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